STIs Flashcards

1
Q

Most common STI

A

Chlamydia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Impact of STI highest in

A

Heterosexuals under 25
MSM
Black ethnic minorities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Largest STI diagnosis increase in MSM

A

Syphilis up 20%

Gonorrhoea up 22%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chlamydia Trachomatis

A

Obligate intracellular pathogen

Asymptomatic infection common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Serovar

A

Distinct variation within species of bacteria or virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chlamydia Serovars D-K

A

Most UTIs
Males- urethritis, epididymitis, prostatitis
Females- Cervicitis, PID, Fitz-Hugh Curtis
Neonate- conjunctivitis and pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chlamydia Servars L1-3

A

Lymphogranuloma venerum

–> buboes, proctitis (inflammation of lining of rectum)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chlamydia trachomatis complications

A

Reactive arthritis

Infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Chlamydia trachomatis treatment

A

Doxycyline

Azithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neisseria gonorrhoea- Males

A
Urethritis
Proctitis
Sore throat
Epididymitis
Prostatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neisseria gonorrhoea- Females

A

Cervicitis
PID
Peri-hepatitis
Septic abortion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neisseria gonorrhoea- Neonates

A

Conjunctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neisseria gonorrhoea- complications

A

Septic arthritis
Blindness
Infertility
Septicaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neisseria gonorrhoea- management

A

Ceftriaxone

–> drug resistance increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Genital warts

A

HPV
90% asymptomatic
Multiple sites
Some associated with carcinoma (16,18,31,33)
Increasing incidence ano-genital and oropharyngeal carcinoma
Vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Genital warts management

A

Topical podophyllotoxon
Imiquimod
Cryotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Herpes Simplex Virus 1 + 2

A
HSV-1 = Oral
HSV-2 = Genital
Primary infection
Latency
Reactivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Herpes simplex virus 1+2- management

A

Aciclovir
Famciclovir
Valaciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Syphilis bacteria

A

Treponema pallidum

Gram negative spirochete bacterium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treponema pallidum

A

Primary, secondary, latent, tertiary, congenital
Often asymptomatic in early stages
Diagnosis depends on serology

21
Q

Syphilis treatment

A

Penicillin

Doxycycline

22
Q

Primary Syphilis

A
Chancre (sore) usually single, painless
Dark ground positive
Lymphadenopathy
Serology may be negative
Infectious ++
23
Q

Secondary Syphilis

A
Rash
Fever
Lymphadenopathy
Condyloma lata
Serology positive
Infectious ++
24
Q

HIV Routine testing

A

GUM, Ante-natal, TOP, DDU

New registrations in GP and medical admissions in areas where high prevalence

25
HIV Opportunistic testing of individuals at high risk
``` STI MSM HIV + partner IDU High prevalence country ```
26
HIV Diagnostic testing with indicator clinical conditions
TB/lymphoma
27
Primary HIV infection
Acute retroviral syndrome 75% patients develop symptoms within 2-6 weeks of infection Wide differential diagnosis- glandular fever, flu Increased viral replication Decreased CD4 count Time of high risk of transmission May be HIV antibody negative
28
HIV antibody
Primary HIV infection may be HIV antibody negative HIV RNA/p24 antigen positive HIV antibody can take up to 3 months to become positive
29
Primary HIV 1 infection Common features
``` Headache Lymphadenopathy Pharyngitis Nausea Oral/genital ulceration on occasion Rash Myalgia Fever Fatigue Weight loss Night sweats ```
30
HIV causing disease
Infects CD4+ cells, macrophages and dendritic cells Acute (primary) HIV infection leads to massive CD4+ cell loss Chronic HIV infection associated with on-going CD4+ cell loss, decline in immune function and progressive immunosuppression
31
HIV-associated disease- Direct HIV effect
Wasting Diarrhoea Neurological problems
32
HIV-associated disease- Opportunistic infections
``` Viral Fungal Bacterial Mycobacterial Parasitic INFECTIONS ```
33
HIV-associated disease- Malignancies
Kaposi's sarcoma- affects lining of blood vessels, often appears as skin lesions Lymphoma Carcinoma cervix
34
CD4 count >500
Low risk HIV-related disease
35
CD4 count 350-500
Symptomatic HIV disease possible
36
CD4 count <200
Risk PCP, gut infections
37
CD4 count <100
CMV, MAI, crypto, toxo, KS
38
Aims of antiretroviral therapy
Suppression of HIV replication --> CD4 count recovery --> Immune reconstitution --> Long term reduced risk of morbidity and mortality
39
Antiretroviral Therapy Principles
HAART= highly active antiretroviral therapy 6 classes of ARV drugs available Act during viral replication cycle to prevent production of new HIV particles Combination antiretroviral therapy always At least 3 drugs from at least two classes --> usually 2 NRTIS + NNRTI or PI Lifelong treatment Adherence vital for success --> resistance can develop quickly, and can be transmitted
40
Antiretroviral therapy Drugs
At least 3 drugs from at least 2 classes | Usually 2 NRTIS + NNRTI or PI
41
NRTI
Nucleoside Reverse transcriptase inhibitors Lamivudine Stops RNA synthesis
42
NNRTI
Non-nucleoside reverse transcriptase inhibitors Nevirapine Stops RNA synthesis
43
PI
Protease inhibitors Ritonavir Stops virus protein being cut up
44
Types of antiretroviral drugs
``` Fusion inhibitor Co-receptor antagonist Nucleoside reverse transcriptase inhibitor Non-nucleoside RT inhibitor Integrase inhibitor Protease inhibitor ```
45
Short term SEs HAART
``` Nausea/vomiting/headache Sleep disturbance (efavirenz) ```
46
Long term SEs HAART
``` Lipodystrophy (NRTIs + PIs) Renal dysfunction (tenofovir) Peripheral neuropathy (d4T, AZT, DDI) Lactic acidosis- may be fatal (d4T, DDI) ```
47
Problems with HAART
Long + short term side effects IRIS- paradoxical inflammatory reaction to pathogen Drug interactions Complex regimens/polypharmacy
48
PEP/ PEPSE + PrEP
``` Indications --> High risk sexual exposure <72 hours --> Needlestick Available via virology/GUM/A+E PrEP- safe and efficacious ```
49
HIV management pregnancy
Early HIV screening ARVT for mother- immediate + continued if low CD4, 2nd trimester + discontinued if high CD4 Elective C section- vaginal delivery possible if undetectable HIV load ARVT for infant No breastfeeding --> Reduced risk of transmission from 25 to less than 1%